ASTH vs PACS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: May 18, 2026
ASTH
PACS
Investment Advisor Scores
PACS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ASTH | PACS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.0415 | 15.5521 | PACS |
| PEG Ratio | 0 | 1.0367 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 55.6% | 11.2% | ASTH |
| Earnings Growth | 110.1% | 194.1% | PACS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.5/100 | 60.6/100 | ASTH |
| Profit Margin | 0.9% | 4.5% | PACS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | BUY | Tie |